Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non-controlling interests
Beginning balance (in shares) at Dec. 31, 2020   76,457,000        
Beginning balance at Dec. 31, 2020 $ 1,210,149 $ 765 $ 1,394,009 $ (204,112) $ 12,634 $ 6,853
Ending balance (in shares) at Jun. 30, 2021   78,419,000        
Ending balance at Jun. 30, 2021 1,322,547 $ 784 1,487,103 (193,530) 11,335 16,855
Beginning balance (in shares) at Dec. 31, 2020   76,457,000        
Beginning balance at Dec. 31, 2020 1,210,149 $ 765 1,394,009 (204,112) 12,634 6,853
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 64,525     64,159   366
Unrealized gain (loss) on available-for-sale securities (8,268)       (8,219) (49)
Unrealized gain (loss) on interest rate swaps 3,351       3,331 20
Issued shares of common stock (in shares)   2,496,000        
Issued shares of common stock 151,701 $ 25 151,676      
Equity-based compensation 17,965   5,226     12,739
Issuance (repurchase) of vested equity-based compensation shares (in shares)   323,000        
Issuance (repurchase) of vested equity-based compensation shares (14,017) $ 3 (14,020)      
Dividends and distributions (86,927)     (85,980)   (947)
Ending balance (in shares) at Sep. 30, 2021   84,275,000        
Ending balance at Sep. 30, 2021 1,473,385 $ 843 1,671,747 (225,933) 7,746 18,982
Beginning balance (in shares) at Jun. 30, 2021   78,419,000        
Beginning balance at Jun. 30, 2021 1,322,547 $ 784 1,487,103 (193,530) 11,335 16,855
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (3,099)     (2,838)   (261)
Unrealized gain (loss) on available-for-sale securities (900)       (896) (4)
Unrealized gain (loss) on interest rate swaps (2,703)       (2,693) (10)
Issued shares of common stock (in shares)   857,000        
Issued shares of common stock 48,812 $ 9 48,803      
Equity-based compensation 3,715   985     2,730
Conversion of Convertible Notes (in shares)   4,999,000        
Conversion of Convertible Notes 134,906 $ 50 134,856      
Dividends and distributions (29,893)     (29,565)   (328)
Ending balance (in shares) at Sep. 30, 2021   84,275,000        
Ending balance at Sep. 30, 2021 $ 1,473,385 $ 843 1,671,747 (225,933) 7,746 18,982
Ending balance (in shares) at Dec. 31, 2021 85,326,781 85,327,000        
Ending balance at Dec. 31, 2021 $ 1,566,515 $ 853 1,727,667 (193,706) 9,904 21,797
Ending balance (in shares) at Jun. 30, 2022   87,490,000        
Ending balance at Jun. 30, 2022 $ 1,591,515 $ 875 1,811,889 (232,590) (22,132) 33,473
Beginning balance (in shares) at Dec. 31, 2021 85,326,781 85,327,000        
Beginning balance at Dec. 31, 2021 $ 1,566,515 $ 853 1,727,667 (193,706) 9,904 21,797
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 62,107     61,431   676
Unrealized gain (loss) on available-for-sale securities (56,855)       (56,236) (619)
Unrealized gain (loss) on interest rate swaps 31,910       31,563 347
Issued shares of common stock (in shares)   3,126,000        
Issued shares of common stock 126,827 $ 31 126,796      
Equity-based compensation 17,994   2,545     15,449
Issuance (repurchase) of vested equity-based compensation shares (in shares)   103,000        
Issuance (repurchase) of vested equity-based compensation shares (3,212) $ 1 (3,213)      
Conversion of Convertible Notes (in shares)   283,000        
Conversion of Convertible Notes 7,674 $ 3 7,671      
Dividends and distributions $ (101,934)     (99,142)   (2,792)
Ending balance (in shares) at Sep. 30, 2022 88,838,705 88,839,000        
Ending balance at Sep. 30, 2022 $ 1,651,026 $ 888 1,861,466 (231,417) (14,769) 34,858
Beginning balance (in shares) at Jun. 30, 2022   87,490,000        
Beginning balance at Jun. 30, 2022 1,591,515 $ 875 1,811,889 (232,590) (22,132) 33,473
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 34,941     34,534   407
Unrealized gain (loss) on available-for-sale securities (12,697)       (12,516) (181)
Unrealized gain (loss) on interest rate swaps 20,109       19,879 230
Issued shares of common stock (in shares)   1,346,000        
Issued shares of common stock 49,033 $ 13 49,020      
Equity-based compensation 2,060   606     1,454
Issuance (repurchase) of vested equity-based compensation shares (in shares)   3,000        
Issuance (repurchase) of vested equity-based compensation shares (49)   (49)      
Dividends and distributions $ (33,886)     (33,361)   (525)
Ending balance (in shares) at Sep. 30, 2022 88,838,705 88,839,000        
Ending balance at Sep. 30, 2022 $ 1,651,026 $ 888 $ 1,861,466 $ (231,417) $ (14,769) $ 34,858